𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hepatitis C virus antibodies among risk groups in Turkey

✍ Scribed by I. Köksal; F. Koç; K. Biberoğlu; S. Biberoğlu; F. Aker; Y. Ayma; H. Köksal

Publisher
Springer-Verlag
Year
1991
Tongue
English
Weight
278 KB
Volume
19
Category
Article
ISSN
0300-8126

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis C virus antibodies among risk
Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus
✍ Dr. P. N. Soni; D. R. Tait; D. G. Kenoyer; F. Fernandes-Costa; S. Naicker; W. Go 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 468 KB

## Abstract The prevalence of anti‐HCV was studied in a South African area endemic for hepatitis B virus. A total of 35,685 volunteer blood donors (22,034 whites, 9,218 Asians, 3,077 Africans, 1,356 coloureds), 71 haemophiliacs, 84 chronic dialysis patients, 100 antenatal attenders, 212 nurses, and

Hepatitis C virus infection and genotype
Hepatitis C virus infection and genotypes among human immunodeficiency virus high-risk groups in Cameroon
✍ Jean Ndjomou; Bernd Kupfer; Bettina Kochan; Leopold Zekeng; Lazare Kaptue; Bertf 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

## Abstract Parenteral transmission of HCV is well established but other possible routes such as heterosexual transmission are still questioned. The Central African region is characterised by a high HCV endemicity without any evidence on the route of transmission. The information on HCV genotypes t

Improved detection of hepatitis c virus
Improved detection of hepatitis c virus antibodies in high-risk populations
✍ John G. McHutchison; John L. Person; Sugantha Govindarajan; Boontar Valinluck; T 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 843 KB

Sera from 483 patients at high (group 1, n = 313) and lower (group 2, n = 170) risk for exposure to hepatitis C were tested for antibodies to hepatitis C using first-generation (c100-3) and second-generation enzyme-linked immunosorbent assays and four-antigen recombinant immunoblot assay. The second